轻度肺动脉压升高可预测不明原因呼吸困难患者死亡率
该研究在547例不明原因呼吸困难和/或肺动脉高压(PH)风险患者中,评估静息平均肺动脉压(mPAP)与全因死亡率的关系。CART分析识别出mPAP 17 mmHg和26 mmHg两个预后阈值,多因素分析显示临界mPAP(20-25 mmHg)和明显PH与生存不良独立相关。
要点
- CART分析识别mPAP预后阈值为17 mmHg和26 mmHg,生存率随mPAP升高显著下降。
- 多因素校正后,临界mPAP(20-25 mmHg,HR 2.37)和明显PH(HR 5.05)与生存不良独立相关。
- 静息mPAP轻度升高(未达PH定义)应视为死亡风险增加的独立预测因素。
核心结论
- 在PH风险或不明原因呼吸困难患者中,CART分析检测到静息mPAP预后阈值为17 mmHg和26 mmHg,20-25 mmHg之间的值代表生存不良的独立预测因素。
研究设计与样本
- 回顾性和前瞻性队列研究,纳入547例不明原因呼吸困难和/或PH风险患者。
- 采用CART分析(无预设阈值)和基于文献的预设阈值(lower-normal、upper-normal、borderline、manifest PH)计算预后截点。
- 进行单变量和多变量生存分析,校正年龄和合并症。
主要发现
- 547例患者中,lower-normal、upper-normal、borderline mPAP和manifest PH分别为137、56、64和290例。
- CART分析区分三组:mPAP<17 mmHg、17-26 mmHg、>26 mmHg,生存率显著递减。
- 单变量分析显示upper-normal mPAP、borderline mPAP和manifest PH均与生存不良显著相关(对比lower-normal mPAP)。
- 多变量模型仅borderline mPAP(HR 2.37;95%CI 1.14-4.97;P=0.022)和manifest PH(HR 5.05;95%CI 2.79-9.12;P<0.001)与生存不良显著相关。
关键数值与推荐
- 正常mPAP定义为14.0±3.3 mmHg(mean±SD)。
- PH定义:mPAP≥25 mmHg。
- lower-normal:≤mean+1 SD;upper-normal:mean+1 SD至mean+2 SD之间;borderline:mean+2 SD至25 mmHg之间;manifest PH:≥25 mmHg。
- CART分析预后阈值:mPAP<17 mmHg、17-26 mmHg、>26 mmHg。
临床怎么用
- 对不明原因呼吸困难或PH风险患者,静息mPAP在20-25 mmHg之间时应警惕死亡风险增加。
- mPAP轻度升高但未达PH诊断标准者,需加强随访和风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Normal mean pulmonary arterial pressure (mPAP) is 14.0 ± 3.3 mm Hg (mean ± SD). The prognostic relevance of mildly elevated mPAP not fulfilling the definition of pulmonary hypertension (PH; mPAP ≥ 25 mm Hg) has not been prospectively evaluated in a real-world setting. OBJECTIVES: To assess the association of resting mPAP with all-cause mortality in a retrospective and a prospective cohort of patients with unexplained dyspnea and/or at risk of PH. METHODS: Prognostic cutoffs were calculated by means of 1) classification and regression tree (CART) analysis without any preset thresholds, and 2) preset thresholds on the basis of literature data defining mPAP as lower-normal (≤mean + 1 SD), upper-normal (between mean + 1 SD and mean + 2 SD), borderline (between mean + 2 SD and 25 mm Hg), and manifest PH (≥25 mm Hg). We performed univariate and multivariate survival analysis adjusted for age and comorbidities. MEASUREMENTS AND MAIN RESULTS: We enrolled 547 patients, of whom 137, 56, 64, and 290 presented with lower-normal, upper-normal, or borderline mPAP, and manifest PH, respectively. The CART analysis on mPAP discriminated three prognostic groups: mPAP less than 17 mm Hg, 17 to 26 mm Hg, and greater than 26 mm Hg, with significantly decreasing survival. The univariate analysis on the basis of preset thresholds showed that upper-normal mPAP, borderline mPAP, and manifest PH were significantly associated with poor survival compared with lower-normal mPAP. In the multivariate model, considering age and comorbidities, only borderline mPAP (hazard ratio, 2.37; 95% confidence interval, 1.14-4.97; P = 0.022) and manifest PH (hazard ratio, 5.05; 95% confidence interval, 2.79-9.12; P < 0.001) were significantly associated with poor survival. CONCLUSIONS: In patients at risk for PH and/or with unexplained dyspnea, CART analysis detects prognostic thresholds at a resting mPAP of 17 mm Hg and 26 mm Hg, and values between 20 mm Hg and 25 mm Hg represent an independent predictor of poor survival. Clinical trial registered with www.clinicaltrials.gov (NCT 01607502).
引用
- Douschan P, Kovacs G, Avian A, et al. Mild Elevation of Pulmonary Arterial Pressure as a Predictor of Mortality. Am J Respir Crit Care Med. 2018. PMID: 29099619. doi:10.1164/rccm.201706-1215OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。